Author:
Kumar Akshay,Thite Sania,Wazarkar Varad,Ayyat Kamal,Gomez Abraham Jesus,Keshavamurthy Suresh
Abstract
Heart and lung transplantations are established treatments for patients with end-stage heart and lung failure, respectively. As mechanical circulatory devices, extracorporeal membrane oxygenation, organ perfusion, and transport systems advance, so do patient comorbidities and profiles of patients undergoing transplantation are becoming more complex. With the ever-increasing shortage of donor organs, marginal and high-risk donor utilization continues to rise. In this chapter, we attempt to elucidate the recent advances and outcomes in heart and lung transplantation. We also highlight how an ongoing COVID-19 pandemic affects the logistics of transplant programs.
Reference102 articles.
1. International Society for Heart and Lung Transplantation. Adult and pediatric lung transplants: Number of transplants by year and procedure type. JHLT. 2019;38(10):1015-1066
2. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2020 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration; 2022
3. Bock MJ, Vaughn GR, Chau P, Berumen JA, Nigro JJ, et al. Organ transplantation using COVID-19-positive deceased donors. American Journal of Transplantation. 2022;22(9):2203-2216. DOI: 10.1111/ajt.17145
4. Eichenberger EM, Coniglio AC, Milano C, Schroder J, Bryner BS, et al. Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases. The Journal of Heart and Lung Transplantation. 2022;41(10):1376-1381. DOI: 10.1016/j.healun.2022.06.018
5. International Society for Heart and Lung Transplantation. Adult lung transplants: Recipient characteristics. JHLT. 2021;40(10):1023-1072